Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
In the last three months, 5 analysts have published ratings on Avantor (NYSE:AVTR), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 4 | 1 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 2 | 1 | 0 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $26.6, a high estimate of $31.00, and a low estimate of $23.00. This current average represents a 6.34% decrease from the previous average price target of $28.40.
In examining recent analyst actions, we gain insights into how financial experts perceive Avantor. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Catherine Schulte | Baird | Raises | Outperform | $27.00 | $26.00 |
Conor McNamara | RBC Capital | Raises | Outperform | $31.00 | $30.00 |
Patrick Donnelly | Citigroup | Lowers | Neutral | $23.00 | $30.00 |
Vijay Kumar | Evercore ISI Group | Lowers | Outperform | $27.00 | $28.00 |
Luke Sergott | Barclays | Lowers | Overweight | $25.00 | $28.00 |
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Avantor's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Avantor analyst ratings.
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Avantor faced challenges, resulting in a decline of approximately -5.65% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Avantor's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 3.6%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Avantor's ROE stands out, surpassing industry averages. With an impressive ROE of 1.14%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.47%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 1.0, Avantor faces challenges in effectively managing its debt levels, indicating potential financial strain.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AVTR